Fish Lea, Leibovich Benjamin, Krigel Yuri, McElwain Terry, Shkap Varda
Division of Parasitology, Kimron Veterinary Institute, Bet Dagan 50250, Israel.
Vaccine. 2008 Dec 19;26 Suppl 6:G29-33. doi: 10.1016/j.vaccine.2008.09.070.
Susceptible dairy cattle were immunized with attenuated, live calf-derived, in vitro-cultured or biologically cloned Babesia bovis, with non-viable exoantigens, or with recombinant rhoptry-associated protein 1 (rRAP1). Antibody response assessed by the indirect fluorescent assay (IFA) and by the growth inhibition activity in vitro showed that seroconversion correlated with neutralization activity in vitro in all immunized groups, but not with protective immunity in vivo. The protective responses elicited by immunization with completely avirulent biologically cloned live parasites, or by the exoantigens were sufficient for highly susceptible dairy cattle, in which prime immunization with blood-derived attenuated parasites cause clinical babesiosis. Upon challenge with virulent live parasites all immunized calves were solidly protected, but only partial protective immunity was acquired by rRAP1 immunization.
用减毒的、源自犊牛的体外培养或生物克隆的牛巴贝斯虫、无活性外抗原或重组棒状体相关蛋白1(rRAP1)对易感奶牛进行免疫接种。通过间接荧光抗体试验(IFA)和体外生长抑制活性评估的抗体反应表明,在所有免疫组中,血清转化与体外中和活性相关,但与体内保护性免疫无关。用完全无毒的生物克隆活寄生虫或外抗原进行免疫接种所引发的保护性反应,对于高度易感的奶牛来说是足够的,这些奶牛用血液来源的减毒寄生虫进行初次免疫会导致临床巴贝斯虫病。在用强毒活寄生虫进行攻毒后,所有免疫的犊牛都得到了可靠的保护,但rRAP1免疫只获得了部分保护性免疫。